NIH Establishes Office To Probe Science Misconduct

WASHINGTON—If NIH is the crown jewel of federal biomedical research, then scientific misconduct is a scratch on its surface. And Brian Kimes is the man that NIH officials hope will begin to restore the luster their organization has lost in the eyes of Congress and the public. On April 10 Kimes became acting director of the newly formed Office of Scientific Integrity (OSI). The office was created by officials within the Public Health Service, NIH’s parent agency, as part of a two-

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

WASHINGTON—If NIH is the crown jewel of federal biomedical research, then scientific misconduct is a scratch on its surface. And Brian Kimes is the man that NIH officials hope will begin to restore the luster their organization has lost in the eyes of Congress and the public.

On April 10 Kimes became acting director of the newly formed Office of Scientific Integrity (OSI). The office was created by officials within the Public Health Service, NIH’s parent agency, as part of a two-step process to deal with misconduct in all programs funded by the agency. It will take over many of the duties now performed by the beleaguered institutional liaison office headed by Janet Newburgh.

Agency officials hope that the new mechanism will convince Congress that NIH is capable of rooting out, and ultimately preventing, most cases of misconduct by scientists. Its duties, as spelled out in the March 18 Federal ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jeffrey Mervis

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio 
Zymo Research

Zymo Research Launches Microbiome Grant to Support Innovation in Microbial Sciences